Bechs Biotech Holding ApS: Financial statements 2024
CVR: 43342452
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Bechs Biotech Holding ApS (CVR 43342452) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,188 and a net result of DKK -1,188 compared with DKK -1,108 the year before. Equity in the 2024 report amounted to DKK 44,056. The solvency ratio was 100%.
- Gross Profit
- DKK -1,188
- Profit/Loss
- DKK -1,188
- Equity
- DKK 44,056
- Total Assets
- DKK 44,056
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Bechs Biotech Holding ApS has published its annual report for 2023. Gross profit came to DKK -1,108, and the net result was DKK -1,108.
As of February 1, 2024, Signe Bech Bruntse is registered as an owner of Bechs Biotech Holding ApS with an ownership share of 20%.
As of February 1, 2024, Ejner Bech Jensen is registered as an owner of Bechs Biotech Holding ApS with an ownership share of 50%.
As of February 1, 2024, Anders Bech Bruntse is registered as an owner of Bechs Biotech Holding ApS with an ownership share of 20%.
About Bechs Biotech Holding ApS
Bechs Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejner Bech Jensen. The company is owned by Signe Bech Bruntse, Ejner Bech Jensen and Anders Bech Bruntse. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,300 and a net result of DKK -1,300 compared with DKK -1,188 the year before. Equity in the 2025 report amounted to DKK 49,700.